Post by Alira Health

Projected to reach $143.6B by 2030 and growing at an 8.3% CAGR, the global medtech CDMO market is entering a new phase defined by consolidation, capability expansion, and accelerating pharma-medtech convergence. How can market stakeholders adapt to this shifting competitive landscape and where are CDMOs investing to keep pace? Whether you are a medtech company, a CDMO, or a private equity, you will find valuable insights to influence your strategic decisions in our signature report on the medtech CDMO market. Click right to preview the 2026 Global Medtech Contract Development and Manufacturing Report and download the full report here: https://lnkd.in/eTNK_yZk